| Financial Year |
March 31 2023 |
| Monetary Funds |
47,863,856.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,031,986.30 |
| Accounts Receivable |
113,324,209.36 |
| Advances to Suppliers |
85,287,093.24 |
| Other Receivables |
8,400,160.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,000,000.00 |
| Inventories |
390,745,965.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,752,280.56 |
| Total Current Assets |
670,405,552.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
190,098,677.83 |
| Investment Properties |
-- |
| Fixed Assetes |
317,001,879.27 |
| Under-construction Projects |
22,943,112.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
87,828,422.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,747,944.47 |
| Deferred Income Tax Assets |
6,054,649.17 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
687,657,783.41 |
| Total Assets |
1,358,063,335.90 |
| Short-Term Loans |
253,207,017.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
63,826,840.00 |
| Accounts Payable |
56,719,955.79 |
| Accounts Received In Advance |
26,999,006.40 |
| Employee Compensation Payable |
5,592,206.07 |
| Taxes Payable |
2,399,735.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,517,174.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
927,686.82 |
| Sub-Total of Current Liabilities |
422,396,564.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,427,267.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,737,767.05 |
| Total Liabilities |
434,134,331.39 |
| Paid-In Capital(Or Share Stock) |
252,888,780.00 |
| Capital Surplus |
359,162,115.34 |
| Surplus Reserve |
44,938,938.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
258,044,007.28 |
| Minority Stockholder's Interest |
-54,004.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
923,983,008.83 |
| Owner's Equity（Stockholder's Equity） |
923,929,004.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,358,063,335.90 |
